Sign in
Stories
Investor Lawsuits in Biotech Industry
Share
Biotech Legal Updates: Lawsuits & Dismis...
Investor Lawsuits and Investigations Unf...
Legal Actions Shake Markets
Alleged Investor Misconduct Lawsuits Ale...
AlloVir Class Action Lawsuit Filed
Altimmune Faces Investor Investigation
Overview
API
Investors in BioNTech SE and BioVie Inc. are urged to contact the Portnoy Law Firm due to lawsuits alleging misleading statements. Additionally, Ventyx Biosciences, Inc. faces a class action for allegedly misrepresenting the efficacy of its psoriasis drug.
Ask a question
Could stricter regulations prevent such instances of alleged misleading statements in the biotech sector?
How might these lawsuits affect the reputation and future investments in the biotech industry?
What measures can biotech companies take to ensure transparency and accuracy in their communications with investors?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Mar 2024
Coverage